Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101
CLEVELAND, June 09, 2023 -- Abeona Therapeutics Inc. today announced that it received feedback from the U.S. Food and Drug Administration on June 8, 2023, in which the Company gained the... | June 9, 2023